Changes in PD-L1 expression on microvessel endothelial cells during melanoma tumor growth and the regulation by anlotinib
Authors:
Preprint
- 10 August 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
To evaluate the expression of PD-L1 on MEC in tumor and normal tissues, IF was used to detect the expression of PD-L1+CD31+ VECs and PD-L1+ Podoplanin + LECs in tumor, ear and kidney tissues. We found that the MEC PD-L1 in tumor showed an upward trend with tumor progression. The expression of PD-L1 in MEC in normal tissues is associated with the type of microvessels and tumor progression. The MEC PD-L1 expression in tumor is significantly down-regulated at 22th day in An5-9 group. In the early treatment group (An5-9), anlotinib increased the LEC PD-L1 but had no significant effect on VEC PD-L1 of ear, while decreased the LEC PD-L1 in kidney. In conclusion, the MEC-PD-L1 in melanoma increased with tumor growth and was downregulated significantly by early treatment of anlotinib, which proposes a potentiality of its enhancement on the therapeutic efficacy of anti-PD-L1 antibody. Anlotinib had no significant effect on the MEC PD-L1 of ear excepting the upregulation of LEC PD-L1 in early treatment group, while decreased such expression in kidney, hence the risk of possible renal damage by CD8 + T cells in the treatment of anlotinib should be bewared.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Podoplanin-Expressing Cells Derived From Bone Marrow Play a Crucial Role in Postnatal Lymphatic NeovascularizationCirculation, 2010
- The role of HIF prolyl hydroxylases in tumour growthJournal of Cellular and Molecular Medicine, 2010
- A New Computational Tool for the Phenomenological Analysis of Multipassage Tumor Growth CurvesPLOS ONE, 2009
- Interferon regulatory factor‐1 is prerequisite to the constitutive expression and IFN‐γ‐induced upregulation of B7‐H1 (CD274)FEBS Letters, 2006
- Current topics of physiology and pharmacology in the lymphatic systemPharmacology & Therapeutics, 2005
- Angiogenesis Induced by Endothelial Nitric Oxide Synthase Gene Through Vascular Endothelial Growth Factor Expression in a Rat Hindlimb Ischemia ModelCirculation, 2003
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationJournal of Experimental Medicine, 2000
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997